Benign multicystic peritoneal mesothelioma mimicking recurrence of an ovarian borderline tumor: a case report

Benign multicystic peritoneal mesothelioma (BMPM) is a rare peritoneal condition which occurs most frequently in women with a history of abdominal surgery. It is characterized by a slowly progressive process and a high rate of relapse after surgical resection [1]. Preoperative or intraoperative diagnosis has been shown to be difficult, especially the differential diagnosis of an ovarian tumor. It is also difficult to manage this disease appropriately because of its rarity.

A 20-year-old Japanese woman presented to a local hospital with lower abdominal pain. She had mental retardation and epilepsy, and was unable to indicate her intentions. She was found to have a multicystic tumor in her pelvic cavity and was referred to our gynecologic department. Her lower abdomen was soft and showed slight swelling without tenderness. Magnetic resonance imaging revealed that a multicystic tumor occupied her abdominal cavity. Because the tumor did not have a solid component or enhancement with gadolinium enhancement and tumor markers were normal (carbohydrate antigens [CA] 125, CA19-9 and carcinoembryonic antigen), a benign ovarian tumor was suspected. A laparotomy was performed, unexpectedly revealing swelling of her bilateral ovaries. The right ovarian tumor was the size of an adult head and the left ovarian tumor was the size of a fist. A right oophorectomy and left ovarian cystectomy were performed. Gross findings were that the bilateral ovarian tumors seemed benign without a solid or papillary component. The pathological diagnosis of the right ovarian tumor was mucinous cystadenoma; however, the pathological diagnosis of the left ovarian tumor was an intestinal type mucinous borderline tumor. Our patient did not receive any adjuvant therapy and we planned to follow up every three months.

Two years and nine months after the primary surgery, a multilocular tumor, approximately 10 cm in diameter, was detected in her pelvic cavity on follow-up ultrasonography. A computed tomography scan revealed a multicystic tumor in her pelvic cavity, without contrast by a radiopaque agent (Figure 1). Magnetic resonance imaging revealed round cystic lesions in her pelvis, with low to intermediate intensity on T1-weighted images and high intensity on T2-weighted images (Figure 2). A small part of the cyst wall was slightly enhanced with the administration of gadolinium. The preserved left ovary was not separately identified. Therefore, a recurrent ovarian borderline tumor was suspected.

Our patient could not give her own opinion regarding her disease so her parents made all decisions regarding her treatment. Our patient had suffered from dysmenorrhea for a long time and her parents therefore requested removal of her uterus and remaining ovary.

Our patient then underwent a second surgery and a multicystic tumor measuring 10 × 10 cm was found in her pelvic cavity. The tumor consisted of many non-isolated cysts of diverse sizes (Figure 3), which adhered to the surface of her ovary, mesentery, mesocolon and pelvic wall. Slight transparent ascites was present. Her uterus was normal and her left ovary was thumb-sized without swelling. A hysterectomy, left oophorectomy, omentectomy, pelvic lymph node biopsy, appendectomy and tumorectomy of her abdomen were performed. Complete resection of the lesion was achieved.

On histology, epithelium with a mucinous component was not seen in the cyst or cyst wall (Figure 4). In the removed left ovary, a tiny component of mucinous cystadenoma was present though neither a mucinous borderline tumor nor a mucinous adenocarcinoma was present. Immunohistochemical staining of the lining cells of the cyst wall were positive for calretinin and Wilms’ tumor protein and negative for D2-40. The removed uterus, lymph nodes and omentum were normal. Our patient was finally diagnosed with BMPM. She recovered uneventfully and was discharged from the hospital on the seventh day after the operation. Our patient received estrogen replacement therapy and remains free from recurrence nine months after the second operation.

Peritoneal mesothelioma is an uncommon lesion that originates from mesothelial cells lining the human body cavities. The incidence is approximately one per 1,000,000 and makes up approximately one-fifth to one-third of all mesotheliomas [2]. Of these peritoneal mesotheliomas, BMPM was reported to constitute about 3% to 5% and only about 130 cases of BMPM have been reported [3], beginning with the first report by Mennemeyer and Smith in 1979 [4]. The pathogenesis of BMPM is controversial. Some authors believe that the lesion is neoplastic because two cases were reported as malignant transformations of BMPM [3, 5]. Others believe the pathogenesis to be a reactive process because of the close relationship between BMPM and a history of abdominal surgery, such as hysterectomy and tubal ligation. In addition, endometriosis may result from a peritoneal reaction to chronic stimuli [1, 6, 7]. Unlike pleural mesothelioma, BMPM is not associated with prior exposure to asbestos.

Among women who wish to have their fertility preserved, it is quite worthwhile to distinguish BMPM from an ovarian tumor intraoperatively. In a review of seven cases of mesothelial tumor, four cases with a benign mesothelial tumor were initially suspected to have ovarian tumors before surgery [8]. Although a few cases have been diagnosed as BMPM before surgery by aspiration cytology [9] or during surgery by histological diagnosis using a frozen section [10], it is difficult to correctly diagnose and treat this disease. Surgery is reported to be the only effective treatment for BMPM, and adjuvant chemotherapy and radiotherapy are not indicated because these tumors have a prevailing benign character [1]. Patients do, however, have a 30-50% risk of recurrence, from one month to many years postoperatively [10]. Therefore, it is necessary to follow up after the resection of BMPM.

The influence of estrogen on BMPM is not well understood. The reduction of cyst volume and cyst growth after therapy with gonadotropin-releasing hormone agonist [11] and the anti-estrogen agent tamoxifen [12] lend further support to the theory that BMPM is an estrogen-dependent condition. The biological rationale for this response, however, remains unexplained; immunohistochemical detection of estrogen receptors and progesterone receptors was reported to be uncommon [6]. Moreover, BMPM has been reported even in male patients [13]. As mentioned above, our patient is now receiving estrogen replacement therapy in order to prevent osteoporosis or symptoms occurring due to the lack of ovarian function.

We present a case of BMPM mimicking the recurrence of an ovarian borderline tumor. BMPM should be suspected when a multicystic lesion is present in the pelvis as in the case presented here, especially in patients with previous abdominal surgery. It is necessary to closely monitor for recurrence after surgery for mucinous borderline tumors in particular, because they seem to be the most difficult to distinguish. More case series are needed in order to reveal this unknown etiology.

The patient had mental retardation and epilepsy, and was unable to indicate her intentions. Therefore, written informed consent was obtained from the patient’s parents for publication of this manuscript and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.